Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You might well have more shares than me Duble....well done.
That must explain why you're so much more negative than I and most here on this board that are also invested, because you're more exposed...makes sense.
Yes broker low ball valuation was £190m which is based on 10% capacity utilisation only plus bottom end estimates for CD4 and Food tolerance. Top end is something like £920m or £980m can't remember which. It's hard to see capacity utilisation at only 10% with the scale and severity of the pandemic.
Think it was 190m Mars but cant be certain
Unvrkw. Things aren't looking good atall in America. The authorities have had to put some counties back into lockdown. Bars opened then had to close again. I got a horrid suspicion we are heading for the same trouble here. Nightmare.
It’s one of the pillars, food intolerance through China is huge. Sell a few million of those at $15.5 each and you make serious money
Sell millions of cd4 then you make money and then and as well all Covid related products, once the POC tests are in place they come of the product lines and replace more expensive alternatives. As we go into a winter do you not think government will have them stacked up ready to go based on test accuracy and sensitivity
Anyway I should`nt be so down, its omlette and chips tonight !!
Anyone recall the minimum brokers value presumably that is where they would expect the value to be now?
The Mrs still has £5k and after all I`m trying not to be negative here just more realistic than I`ve been to myself over the last 2 months . If the share price has gone back 70+ then we`d all be saying how brilliant every thing was but it is`nt. Also this is one of the massive pillars of progress that the company has rightly set out yet the share price has`nt reflected it whatsoever in fact its worse than even ramirez could have predicted, which is saying something!
@Biglad.....you've sold out. Why hang about?
The brokers upper end valuation from the placing document is £980m given capacity that is available. Only £902m to go.
Well said Green, I've just cracked an Aldi Den Velda Pilsner (the green in Dutch) to celebrate future profits!
Green. My sentiment exactly.
Good point mars! Stand corrected. I was thinking entire capacity percentages.
The placing price represents the current value of the business excluding covid, china food detective and Cd4 as per Finncap. This gives II's and PI's potential upside in coming years for these product areas to provide significant revenues and subsequent value for shareholders. Even at the low end of expectations Odx shareholders should easily double their money in the coming year, albeit caveated by acheiving orders etc. I can also foresee a special dividend being done next year or buy back if all goes well. Nothing is certain but I am happy to hold for another year or so. GLA
The regulator was simply an excuse. What made them issue that the sp had shot up so giving placing shares away at 40p which was what was being agreed would of caused a right fuss.
There are many shares on aim that double in price every day/week and no ticket is ever issued. We were the exception and its cost us all thousands, whatever price you bought at. Its had a terrible knock on effect that has`nt been realised until today that the DF has been built into the placing price, hence the crock of s*** price that we are now looking at. This of course might still be a good investment but we are now starting off at 50p less than we should and we`ve all taken a right rodgering.
It’s 1m lateral flow and 1m Elisa tests per week. The lateral flow is 80/20 but can be moved between RTC and Mologic
Chaps - yes I hold shares here. Prob more than you. But not sure WTF that has got to do with you.
I think the reason for the rise last time was the 50m omega looked to have been producing themselves. We all know that the number is actually going to be 104m per year but it isn't being PR'd anywhere near as good! They said 100k per week on sky news. It just didn't do any justice for Omega this time round.
He didnt stop us the regulator demanded the rns and they were ill advised in writing it. There clearly was a reason for the rise. When your nomad is your broker and also a market maker on the stock its a conflict of interest that shouldnt be allowed.
Notwithstanding your ****sure approach Duble, I don't believe you have informed the rest of the board on whether you actually hold any shares here as yet?
Still can’t see why he stopped us at 90 and made us place at 40. If were a world beater.
Cheemap 20% of 2m is 400k, not 200k. The split doesn't add up unless they are going off the 1m capacity prior to upscale to 2m.
Wonder if CK could come out and talk to investors as a ceo not a scared scientist. Clear up a few concerns or clarification points. If the email posted on Twitter was true looks like it would be something he may do.
Thanks Ton1c and MB - just watched it - got it now so even better.
I do hope the board can return to civil debate and we can lose the abusers now, we can continue to look forward and having listened to the presentation there seems to be continuous news flow through to September are least laid out now with the various updates on trading, CE mark etc...
OK thanks MerchantBanker. Unfortunately due to lockdown home schooling and other things I can't devote the time I'd like to to keeping fully abreast of developments. I decided I was over exposed here and cancelled my entitlement to 40p shares earlier today but now I'm wondering whether to reinstate it. Seems to have been oversold here today for anyone willing to hold until at least end of year.